ABSTRACT
Scleritis can be a severe, destructive, blinding disease requiring immunosuppressive therapy. It may also be a manifestation of a potentially life-threatening systemic autoimmune disease.
Background
Classification of scleritis is based on the anatomical site and clinical appearance of the inflammation at presentation. The inflammation may be divided into anterior and posterior scleritis. Anterior scleritis is further sub-divided into diffuse, nodular and necrotizing with and without inflammation.
